p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancerJinghui Liu, Xiaoqi Liu, Dana Napier et al.|Oncogene|2020Cited by 114
Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancerXiaoliang Chen, Xiaoqi Liu, Jinghui Liu et al.|The Prostate|2019Cited by 33
Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosisChangkun Huang, Xinjun Wang|OncoTargets and Therapy|2018Cited by 27